Navigation Links
Indoor Tanning Association Launches Campaign Attacking Melanoma Hype
Date:3/26/2008

oma: Myth on Myth!

"Both the sun and tanning beds have been unnecessarily demonized by special interests using junk science and scare tactics," says Sarah Longwell, spokeswoman for the ITA. "While our campaign will be controversial, its time people learned the truth about sun exposure. Not only is moderate tanning completely safe, more and more it's becoming just what the doctor ordered."

To schedule an interview, contact Sarah Longwell at 202.420.7865.

The Indoor Tanning Association represents thousands of indoor tanning manufacturers, distributors, facility owners and members from other support industries. The ITA promotes a responsible message about moderate tanning and sunburn prevention.


'/>"/>
SOURCE Indoor Tanning Association
Copyright©2008 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2

Related medicine news :

1. Poor indoor air quality means poorer health for patients with COPD
2. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
3. Classifying indoor tanning behaviors can help physicians tailor prevention messages
4. February is Designated as National Care About Your Indoor Air Month
5. Purdue lab works to improve conditions at indoor swimming pools
6. Teenage girls arent the only ones who tan indoors -- older adults do so as well
7. American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act
8. Kelli Pedroia, Wife of Red Sox Dustin Pedroia, Joins Melanoma Foundation of New England to Warn About Tanning for the Prom
9. Yakima Health Care Leader Tapped for Leadership Post at National Association
10. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
11. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 1Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 2Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 3Sanofi Aventis 3A Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes 4919 4Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 1Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 2Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 4Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 1Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 2Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 3Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 4Abbott Launches Next Generation XIENCE PRIME 28TM 29 Drug Eluting Stent in International Markets 55665 5